The Food and Drug Administration (FDA) has confirmed that Janssen, the pharmaceutical arm of American drugmaker Johnson & Johnson, has applied for emergency use approval (EUA) for its COVID-19 vaccine. “They last Wednesday. Now under evaluation,” Domingo said in a text message to reporters. The company’s vaccine is now on its Phase 3 clinical trial …

The post COVID-19 vaccine: Johnson & Johnson applies for emergency use approval in PH appeared first on The Filipino Times.